AbbVie agrees a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will add an oral peptide for psoriasis to its pipeline.

AbbVie agrees a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will add an oral peptide for psoriasis to its pipeline. Join the conversation, on Tuesday 28th January ...

We recently compiled a list of the 10 Best Dividend Growth Stocks to Buy and Hold in 2025. In this article, we are going to ...

AbbVie (ABBV) closed at $177.70 in the latest trading session, marking a +0.85% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 0.43% for the day. On the other ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other long-term stocks. To select stocks with long-term growth potential, investors should focus on ...

This page features the latest news about the Abbvie stock. AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call NORTH CHICAGO, Ill., Jan. 3, 2025 /PRNewswire/ -- AbbVie (NYSE ...